Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged…

Continue ReadingTirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial

Pneumococcal polysaccharide vaccine Found Ineffective in Reducing Cardiovascular Events, reports JAMA

A new study published in the Journal of American Medical Association found that pneumococcal polysaccharide vaccine (PPV23) vaccination did not reduce rates of fatal and nonfatal acute coronary syndrome or ischemic…

Continue ReadingPneumococcal polysaccharide vaccine Found Ineffective in Reducing Cardiovascular Events, reports JAMA

Regular Exercise After Weight Loss Outperforms GLP-1 Drugs in Reducing MI and Stroke Risk, suggests study

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development…

Continue ReadingRegular Exercise After Weight Loss Outperforms GLP-1 Drugs in Reducing MI and Stroke Risk, suggests study